secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2023-11-01T23:59:59+00:00
Accession:  0001606498-23-000077
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical reports Q3 2023 results; no financial details available in filing text
--------------------------------------------------------------------------------

- Filed 8-K on Nov 1, 2023 announcing Q3 earnings results for period ended Sept 30, 2023.
- Press release issued as Exhibit 99.1 but not included in provided text.
- Unable to extract revenue, EPS, or segment data from available information.
- Recommend reviewing full press release for specific financial figures and guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000077/0001606498-23-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000077/avns-20231101.htm
  HTML page:      https://secwatch.observer/filing/0001606498-23-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer